Latest Breaking News On - Richardk bogan - Page 1 : vimarsana.com

Part 4: LXB as Effective as SXB for Cataplexy, EDS, With Less Sodium

Lower-sodium oxybate (LXB) and sodium oxybate (SXB) were proven equally effective for cataplexy and excessive daytime sleepiness (EDS), despite LXB having 92% less sodium.

United statesRichardk boganAmerican academy of sleep medicineUniversity of south carolina school medicineBogan sleep consultantsAmerican college of chest physiciansAmerican collegeChest physiciansAmerican academySleep medicineSouth carolina schoolAmerican journalBogan sleepSodium oxybateLower sodium oxybateExcessive daytime sleepiness

Oxybate Boosts Narcolepsy Sleep Quality Regardless of Dose

Jazz Pharmaceuticals' review found that oxybate improved measures of sleep in narcolepsy patients, independent of the dosing regimen.

Richardk boganKelvin tanGlobal psychiatry behavioral health learning networkJazz pharmaceuticalsUniversity of south carolina school medicinePsych congressUniversity of south carolinaSouth carolina schoolMedical universitySouth carolinaBehavioral health learning network

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj thorpyVirendk somersRichardk boganJazz pharmaceuticals incMontefiore medical centerWake disorders centerProgram overviewAccreditation council for continuing medical educationCardiometabolic health congressAmerican nurses credentialing centerBogan sleep consultantsAccreditation council for pharmacy educationHealthy hummingDepartment of neurologySpeakers bureau for jazz

Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were.

United statesUniversity of south carolinaSouth carolinaRichardk boganAndrean flynnKelvin tanKristin bhavnaniPsych congressWorld idiopathic hypersomnia total health modelUnmet public health problemIndian journal of medical researchAmerican psychiatric associationNational health serviceNational institute of neurological disordersAmerican academy of sleep medicineHead of global corporate communications

Burden of Idiopathic Hypersomnia

People with idiopathic hypersomnia face a significant disease burden, including challenges that impact daily living activities.

South carolinaUnited statesSree royRichardk boganRichard boganJazz pharmaceuticalsHypersomnia foundationSleep reviewBogan sleep consultantsIdiopathic hypersomnia severity scale